Y-mAbs Therapeutics, Inc. - Common Stock (NQ:YMAB)
All News about Y-mAbs Therapeutics, Inc. - Common Stock
From Brodsky & Smith LLC
Via GlobeNewswire
Y-mAbs (YMAB) Q2 Revenue Falls 14% ↗
August 08, 2025
Via The Motley Fool
Topics
Intellectual Property
From Brodsky & Smith LLC
Via GlobeNewswire